DEF 14A
REGENERON PHARMACEUTICALS, INC.
- Company
- REGENERON PHARMACEUTICALS, INC.
- Filed
- April 30, 2001
- Period of Report
- June 8, 2001
- Accession Number
- 0000950123-01-501439
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →